Anticancer drug delivery for tumor targeting and therapy

4th IEEE International Conference on Nano/Micro Engineered and Molecular Systems, NEMS 2009

Volumn , Issue , 2009, Pages 919-922

  Kim, Yu Jin ^a   Park, Il Kyu ^b   Kim, Jin Soo ^a   Hwang, Joon ^a   Chung, Eui Sik ^c   Huh, Kang Moo ^b   Lee, Yong Kyu ^a  

^a Chungju National University   (South Korea)

^b Chungnam National University   (South Korea)

^c Hanbat National University   (South Korea)

Author keywords

Cancer targeting; EPR; Heparin conjugate; Nanoparticles

Indexed keywords

ANTI-CANCER DRUG DELIVERY; ANTICANCER DRUG; BIO-MOLECULAR; CANCER TARGETING; EPR; FOLIC ACIDS; FOURIER TRANSFORM INFRARED; HEPARIN CONJUGATE; IN-VIVO; MULTIPLE LEVELS; POLYMERIC CARRIERS; PROTON NUCLEAR MAGNETIC RESONANCE; SIDE EFFECT; TARGET CELLS; TEM; TUMOR TARGETING; TUMOR VASCULATURE; ULTRA-VIOLET; WATER SOLUBILITIES;

AMIDES; CHEMICAL WATER TREATMENT; COAGULATION; DRUG DELIVERY; DYNAMIC LIGHT SCATTERING; ELECTRON RESONANCE; ELECTRON SPIN RESONANCE SPECTROSCOPY; ESTERS; INTERNET; LIGHT TRANSMISSION; NANOPARTICLES; NUCLEAR MAGNETIC RESONANCE; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; ORGANIC ACIDS; PARAMAGNETIC RESONANCE; QUANTUM THEORY; SPECTROMETRY; TRANSMISSION ELECTRON MICROSCOPY; TUMORS;

POLYSACCHARIDES;

EID: 70349673949     PISSN: None     EISSN: None     Source Type: Conference Proceeding    
DOI: 10.1109/NEMS.2009.5068724     Document Type: Conference Paper

References (21)

1. R. Duncan, "The dawning era of polymer therapeutics", Nature Rev. Drug Discov., vol. 2, pp.347-360, 2003.
2. C. Li, "Poly(l-glutamic acid)-anticancer drug conjugates", Adv. Drug Deliv. Rev. vol.54, pp.695-713, 2002.
3. ® block copolymers as novel polymer therapeutics for drug and gene delivery", J. Control. Release vol.82, pp.189-212, 2002.
4. V.S. Trubetskoy, and V.P. Torchilin, "Use of polyoxyethylene-lipid conjugates as long-circulating carriers for delivery of therapeutic and diagnostic agents", Adv. Drug Deliv. Rev. vol. 16, pp.311-320, 1995.
5. R.K. Jain, (1996) "Delivery of Molecular Medicine to Solid Tumors", Science, vol.271, pp.l079-1080, 1996.
6. H.Maeda, L.W.Seymour, and Y.Miyamoto, "Conjugates of anticancer agents and polymers: advantages of macromolecular therapeutics in vivo", Bioconjugate Chem. vol.3, pp.351-362, 1992.
7. D.Putnam, and J.Kopecek, "Polymer conjugates with anticancer activity", Adv. Polym. Sci. vol.122, pp.55-123, 1995.
8. J.Fang, T.Sawa, T.Akaike, and H.Maeda, (2002) "Tumor-targeted delivery of polyethylene glycol-conjugated d-amino acid oxidase for antitumor therapy via enzymatic generation of hydrogen peroxide". Cancer Res. vol. 62, pp.3138-3143, 2002.
9. M.Yokoyama, M.Miyauchi, N.Yamada, T.Okano, Y.Sakurai, K.Kataoka, and S.Inoue, "Characterization and anticancer activity of the micelle-forming polymeric anticancer drug adriamycin-conjugated poly(ethylene glycol)-poly(aspartic acid) block copolymer", Cancer Res. vol.50, pp.1693-1700, 1990.
10. V.S. Trubetskoy, and V.P. Torchilin, "Use of polyoxyethylene-lipid conjugates as long-circulating carriers for delivery of therapeutic and diagnostic agents", Adv. Drug Deliv. Rev. vol. 16, pp.311-320, 1995.
11. R.K. Jain, (1996) "Delivery of Molecular Medicine to Solid Tumors", Science vol.271, pp.1079-1080, 1996.
12. H.Maeda, L.W.Seymour, and Y.Miyamoto, "Conjugates of anticancer agents and polymers: advantages of macromolecular therapeutics in vivo", Bioconjugate Chem. vol.3, pp.351-362, 1992.
13. D.Putnam, and J.Kopecek, "Polymer conjugates with anticancer activity", Adv. Polym. Sci. vol.122, pp.55-123, 1995.
14. J.Fang, T.Sawa, T.Akaike, and H.Maeda, (2002) "Tumor-targeted delivery of polyethylene glycol-conjugated d-amino acid oxidase for antitumor therapy via enzymatic generation of hydrogen peroxide". Cancer Res. vol. 62, pp.3138-3143, 2002.
15. M.Yokoyama, M.Miyauchi, N.Yamada, T.Okano, Y.Sakurai, K.Kataoka, and S.Inoue, "Characterization and anticancer activity of the micelle-forming polymeric anticancer drug adriamycin-conjugated poly(ethylene glycol)-poly(aspartic acid) block copolymer", Cancer Res. vol.50, pp.1693-1700, 1990.
16. F. Fuertges, and A. Abuchowski, "The clinical efficacy of poly(ethylene glycol)-modified proteins", J. Control. Release vol.11, pp.139-148, 1990.
17. H.Maeda, "SMANCS and polymer-conjugated macromolecular drugs: advantages in cancer chemotherapy", Adv. Drug Deliv. Rev. vol. 6, pp.181-193, 1991.
18. R.Duncan, and F.Spreafico, "Polymer conjugates. Pharmacokinetic considerations for design and development", Clin. Pharrnacokinet. vol.27, pp.290-306, 1994.
19. P.Sinay, "Synthetic chemistry: Sugars slide into heparin activity. Nature, vol.398, pp.377 - 378, 1999.
20. M. Petitou, J. Hérault, A. Bernat, P.Driguez, P.Duchaussoy, J. Lormeau and J. Herbert",Synthesis of thrombin-inhibiting heparin mimetics without side effects", Nature, vol.398, pp.417 - 422, 1999.
21. J. Folkman, P.B. Weisz, M.M. Joullie, W.W. Li, and W.R. Ewing, "Control of angiogenesis with synthetic heparin substitutes", Science, vol.243, pp.1490-1493, 1989.